Bliss GVS Pharma Limited — Financials & Forensics
NSE: BLISSGVS · BSE: 506197 · ISIN: INE416D01022
₹269.65
Closing price
08 May 2026
08 May 2026
+90.1%
1-year price change
₹2,781 Cr
Market cap
20.6×
P/E ratio (trailing)
11.6%
Return on Equity (FY)
0.39%
Dividend yield
⚡ What you get within minutes of every filing
ISA
Indian Stock Alerts
BOT
🚨 BLISSGVS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add BLISSGVS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
Compare with:
Annual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹747 Cr | ₹752 Cr | ₹770 Cr | ₹810 Cr | ₹927 Cr |
| EBITDA | ₹118 Cr | ₹117 Cr | ₹151 Cr | ₹127 Cr | ₹164 Cr |
| EBITDA margin | 15.8% | 15.6% | 19.6% | 15.7% | 17.7% |
| Profit after tax | ₹23 Cr | ₹77 Cr | ₹82 Cr | ₹90 Cr | ₹135 Cr |
Deeper analysis
Never miss a filing again
1
Sign in with Google
2
Add stocks to watchlist
3
Get instant Telegram alerts
14-day Pro trial included · No credit card required
About Bliss GVS Pharma Limited on Indian Stock Alerts
Indian Stock Alerts tracks Bliss GVS Pharma Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.
Important.
All data on this page is sourced from Bliss GVS Pharma Limited's own
public regulatory filings under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment
Adviser. This page is informational, not investment
advice, a recommendation to buy or sell any security, or any
opinion about the company's business, governance or financial
health. Investors should consult registered advisers before making
investment decisions.